Accumulating evidence has shown that FTO contributes to the development and progression of cancers, including endometrial cancer [4], ovarian cancer [5], pancreatic cancer [6], lung squamous cell carcinoma [7], melanoma [8] and acute myeloid leukemia [9]. The gene discussed is FTO; the disease is melanoma.